Overview of epidemiological situation with regard to MRSA in Germany

NewsGuard 100/100 Score

In German hospitals, each year 132 000 patients contract infection with methicillin-resistant Staphylococcus aureus (MRSA). For more than a decade, different countries have reported an increasing incidence of MRSA infections in the general population ("community associated" [CA-] MRSA).

In the current issue of Deutsches Ärzteblatt International, Robin Köck from the Münster University Hospital and coauthors provide an overview of the epidemiological situation with regard to MRSA in Germany. They present the status quo in institutions within the healthcare sector, but also potential transmission routes in the general population.

The total incidence of nosocomial MRSA infections in Germany has stabilized after a substantial rise in the 1990s. Important risk factors for the acquisition of CA-MRSA include travel to high-prevalence areas, such as the United States, and close contact with people who are infected with CA-MRSA. The identification of individual areas with an increased prevalence of CA-MRSA in Europe does, however, make the occurrence of CA-MRSA increasingly likely.

The zoonotic transmission of MRSA is increasingly gaining in importance. The pathogen is widespread in different species of livestock and easily transmits to humans who are in direct contact with those animals. In domestic animals and pets, MRSA has been confirmed in individual cases, but thus far no exact data are available for Germany.

The new potential transmission routes present new challenges for prevention and control of MRSA. Several national research consortia already contribute to this objective, for example on MRSA in animal reservoirs.

Source:

Deutsches Ärzteblatt International

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel synthetic antibiotic effective against drug-resistant bacteria